Stories about Alnylam Pharmaceuticals
3 Lesser-Known Biotech Stocks that are Surging
January 21, 2021
From Blogs - TalkMarkets
Tags
Stocks
From Market News Video
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
From Benzinga
Alnylam Launches “Alnylam P5x25” Strategy For Planned Transition To A Top Five Biotech In Market Capitalization Over Next Five Years
January 10, 2021
From Blogs - TalkMarkets
Alnylam Pharmaceuticals Larger Than S&P 500 Component IDEX
December 31, 2020
Tags
Stocks
From Market News Video
Analysts Forecast 10% Gains Ahead For The Holdings of BBH
December 24, 2020
Tags
ETFs
From ETF Channel
Interesting ALNY Put And Call Options For February 2021
December 21, 2020
Tags
Stocks
From Market News Video
Should You Buy Sage Stock After the Biogen Investment?
December 19, 2020
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
From Motley Fool
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
From Motley Fool
Are These The Best Biotech Stocks To Watch Right Now? 3 To Consider As Pfizer’s Vaccine Rollout Begins
December 02, 2020
From Stockmarket.com
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
November 28, 2020
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
From Benzinga
Why These 3 Pharma Stocks Are Moving Today
November 24, 2020
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
Tags
Stocks
From Market News Video
12 Healthcare Stocks Moving In Thursday's After-Market Session
October 22, 2020
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.